• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Bayer AG ADR

Bayer AG ADR

Bayer AG ADR BAYRY 3 Star

Last Price$140.41Day Change (%)-0.22%
Open Price$140.49Day Change ($)-0.32
Day Range140.41–141.2052-Week Range124.36–150.63

As of Fri 12/26/2014 04:00 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® (radium Ra 223 dichloride) Injection

    Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® (radium Ra 223 dichloride) Injection

  2. Bayer Plans to Sell Equine-Health Products to Sanofi Unit

    Bayer Plans to Sell Equine-Health Products to Sanofi Unit

  3. Research and Markets: Asia-Pacific Gynecological Devices Market Outlook to 2020: Key players covered include Bayer , Hologic, Boston Scientific, Microsulis Medical, Cook Medical and Merit Medical

    Research and Markets: Asia-Pacific Gynecological Devices Market Outlook to 2020: Key players covered include Bayer , Hologic, Boston Scientific, Microsulis Medical, Cook Medical and Merit Medical

  4. Research and Markets: BRIC Gynecological Devices Market Outlook to 2020: Key players covered include Bayer , Hologic, Boston Scientific, Microsulis, Cook and Merit

    Research and Markets: BRIC Gynecological Devices Market Outlook to 2020: Key players covered include Bayer , Hologic, Boston Scientific, Microsulis, Cook and Merit

  5. Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017

    Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017

  6. Research and Markets: Seeds - Global Strategic Business Report

    Research and Markets: Seeds - Global Strategic Business Report

  7. ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial

    ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial

  8. Research and Markets: Micro Market Monitor: North American Intrauterine Contraceptive Devices Market - Forecasts to 2019

    Research and Markets: Micro Market Monitor: North American Intrauterine Contraceptive Devices Market - Forecasts to 2019

  9. Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

    Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

  10. Research and Markets: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014

    Research and Markets: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.